542 related articles for article (PubMed ID: 37681561)
1. Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis.
Reeve K; On BI; Havla J; Burns J; Gosteli-Peter MA; Alabsawi A; Alayash Z; Götschi A; Seibold H; Mansmann U; Held U
Cochrane Database Syst Rev; 2023 Sep; 9(9):CD013606. PubMed ID: 37681561
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
4. Prognostic models for predicting relapse or recurrence of major depressive disorder in adults.
Moriarty AS; Meader N; Snell KI; Riley RD; Paton LW; Chew-Graham CA; Gilbody S; Churchill R; Phillips RS; Ali S; McMillan D
Cochrane Database Syst Rev; 2021 May; 5(5):CD013491. PubMed ID: 33956992
[TBL] [Abstract][Full Text] [Related]
5. Multi-domain prognostic models used in middle-aged adults without known cognitive impairment for predicting subsequent dementia.
Mohanannair Geethadevi G; Quinn TJ; George J; Anstey KJ; Bell JS; Sarwar MR; Cross AJ
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014885. PubMed ID: 37265424
[TBL] [Abstract][Full Text] [Related]
6. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
[TBL] [Abstract][Full Text] [Related]
7. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.
Wynants L; Van Calster B; Collins GS; Riley RD; Heinze G; Schuit E; Bonten MMJ; Dahly DL; Damen JAA; Debray TPA; de Jong VMT; De Vos M; Dhiman P; Haller MC; Harhay MO; Henckaerts L; Heus P; Kammer M; Kreuzberger N; Lohmann A; Luijken K; Ma J; Martin GP; McLernon DJ; Andaur Navarro CL; Reitsma JB; Sergeant JC; Shi C; Skoetz N; Smits LJM; Snell KIE; Sperrin M; Spijker R; Steyerberg EW; Takada T; Tzoulaki I; van Kuijk SMJ; van Bussel B; van der Horst ICC; van Royen FS; Verbakel JY; Wallisch C; Wilkinson J; Wolff R; Hooft L; Moons KGM; van Smeden M
BMJ; 2020 Apr; 369():m1328. PubMed ID: 32265220
[TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
9. Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.
Aldin A; Umlauff L; Estcourt LJ; Collins G; Moons KG; Engert A; Kobe C; von Tresckow B; Haque M; Foroutan F; Kreuzberger N; Trivella M; Skoetz N
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD012643. PubMed ID: 31525824
[TBL] [Abstract][Full Text] [Related]
10. Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.
Aldin A; Umlauff L; Estcourt LJ; Collins G; Moons KG; Engert A; Kobe C; von Tresckow B; Haque M; Foroutan F; Kreuzberger N; Trivella M; Skoetz N
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012643. PubMed ID: 31930780
[TBL] [Abstract][Full Text] [Related]
11. Machine learning models for diabetes management in acute care using electronic medical records: A systematic review.
Kamel Rahimi A; Canfell OJ; Chan W; Sly B; Pole JD; Sullivan C; Shrapnel S
Int J Med Inform; 2022 Apr; 162():104758. PubMed ID: 35398812
[TBL] [Abstract][Full Text] [Related]
12. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.
Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012200. PubMed ID: 28440858
[TBL] [Abstract][Full Text] [Related]
13. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
14. Eliciting adverse effects data from participants in clinical trials.
Allen EN; Chandler CI; Mandimika N; Leisegang C; Barnes K
Cochrane Database Syst Rev; 2018 Jan; 1(1):MR000039. PubMed ID: 29372930
[TBL] [Abstract][Full Text] [Related]
15. Information provision for people with multiple sclerosis.
Köpke S; Solari A; Rahn A; Khan F; Heesen C; Giordano A
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008757. PubMed ID: 30317542
[TBL] [Abstract][Full Text] [Related]
16. WITHDRAWN: Interventions for fatigue and weight loss in adults with advanced progressive illness.
Payne C; Wiffen PJ; Martin S
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008427. PubMed ID: 28387447
[TBL] [Abstract][Full Text] [Related]
17. Interventions for fatigue and weight loss in adults with advanced progressive illness.
Payne C; Wiffen PJ; Martin S
Cochrane Database Syst Rev; 2012 Jan; 1():CD008427. PubMed ID: 22258985
[TBL] [Abstract][Full Text] [Related]
18. Siponimod for multiple sclerosis.
Cao L; Li M; Yao L; Yan P; Wang X; Yang Z; Lao Y; Li H; Yang K; Li K
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013647. PubMed ID: 34783010
[TBL] [Abstract][Full Text] [Related]
19. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
[TBL] [Abstract][Full Text] [Related]
20. Teriflunomide for multiple sclerosis.
He D; Zhang C; Zhao X; Zhang Y; Dai Q; Li Y; Chu L
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009882. PubMed ID: 27003123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
